Clinical Trial Update: Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a regimen of irinotecan, 5-fluorouracil, and leucovorin for colorectal carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Carcinoma

Drugs mentioned

• 5-Fluorouracil (Adrucil) (5-Fluorouracil)
• Irinotecan (Camptosar) (Irinotecan)
• Leucovorin (folinic acid) (folinic acid)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Colorectal Carcinoma | Phase 2 | Status: COMPLETED